Skip to main content
. 2019 Jul 30;24(15):2772. doi: 10.3390/molecules24152772

Figure 5.

Figure 5

Phase contrast microscope images at 0, 24, 48, and 72 h post-scratch in six human cancer cell lines treated with varying doses of colchicine (2.5–60 nM). (A) A549, (B) HCT116, (C) SiHa, (D) PANC-1, (E) MDA-MB231, and (F) MCF-7.